Iridium-Catalyzed Asymmetric Ring Opening of Azabicyclic Alkenes by Amines
Iridium-Catalyzed Asymmetric Ring Opening of Azabicyclic Alkenes by Amines
Iridium-Catalyzed Asymmetric Ring Opening of Azabicyclic Alkenes by Amines
org/joc
[email protected]; [email protected]
Received July 30, 2010
The enantioselective ring-opening reactions of azabicyclic alkenes with primary and secondary
aromatic amine nucleophiles are reported using an iridium catalyst generated in situ from 1.5 mol %
of [Ir(COD)Cl]2 and 3 mol % of (S)-BINAP. The reaction affords the corresponding trans-1,2-diamine
derivatives in moderate to good yields with moderate to high enantioselectivities (up to 97% ee). The
trans-configuration of the 1,2-diamino product 2g was confirmed by X-ray crystallography.
DOI: 10.1021/jo101470r Published on Web 10/13/2010 J. Org. Chem. 2010, 75, 7291–7299 7291
r 2010 American Chemical Society
JOC Article Long et al.
represents a type of allylic substitution reaction in which the TABLE 1. Ligand Optimization for Iridium-Catalyzed Asymmetric
reaction proceeds under relatively mild conditions, leading to a Ring-Opening of N-Boc-Azabenzonorbornadiene 1 with N-Methylanilinea
variety of 1,2-diamino compounds in both high yields and
excellent enantioselectivities. Lautens and co-workers16 have
extensively investigated Rh-catalyzed asymmetric ring-opening
reactions of azabenzonorbornadienes with amines (up to 99%
ee) and successfully employed them in the preparation of new
chiral ligands17 and analgesic compounds.18 Recently, we have
reported Rh-19 and Ir-catalyzed20 asymmetric ring-opening
reactions of N-Boc-azabenzonorbornadiene with N-substi-
tuted piperazine nucleophiles in high yields and high enantio-
selectivities. Our interest in generating carbon-nitrogen bonds
has prompted us to expand the scope of the reaction to include
primary aromatic amine as well as cyclic and acyclic secondary
amine-induced ring openings of azabicyclic alkenes for an
efficient access to trans-1,2-diamine moieties with high regio-,
diastereo-, and enantioselectivities. These methods offer poten-
tially useful synthetic routes to trans-1,2-diamines which are the
scaffolds for chiral ligands21 and valuable intermediates for
total synthesis of bioactive compounds.22
In this paper, we report the full details of the catalytic asym- entry [Ir(COD)Cl]2 ligand yieldb (%) eec (%)
metric ring-opening reactions of N-substituted azabenzonorbor-
1 1.0 mol % 2 mol % DPPF 71 0
nadienes 1, 3, and 5 with a wide variety of amines in the presence 2 1.5 mol % 3 mol % DPPF 86 0
of iridium catalysts. The reaction affords the corresponding 3 2.0 mol % 4 mol % DPPF 83 0
trans-1,2-diamine derivatives in moderate to good yields with 4 1.5 mol % 3 mol % (R)-(S)-PPF-PtBu2 10 20
moderate to excellent enantioselectivities (up to 97% ee). 5 1.5 mol % 3 mol % (S)-(R)-NMe2- nr
PPh2-Mandyphos
6 1.5 mol % 3 mol % (S)-BINAP 56 84
Results and Discussion 7 1.5 mol % 3 mol % (S)-p-Tol-BINAP 10 70
8 1.5 mol % 3 mol % L1 nr
The substrates 1, 3, and 5 were prepared according to the 9 1.5 mol % 1.5 mol % (S)-BINAP 6 43
literature procedures.20a,7,16b An achiral ligand 1,10 -bis(diphenyl- 10 1.5 mol % 4.5 mol % (S)-BINAP 30 62
phosphino)ferrocene (DPPF) was first chosen to validate the a
The reaction was carried out with 1 (0.21 mmol) and 3.0 equiv of
N-methylaniline (0.63 mmol) in THF (2.0 mL) at 80 °C (oil bath
(15) For selected recent examples on iridium-catalyzed allylations, see: temperature). bIsolated yield after silica gel column chromatography.
c
(a) Raskatov, J. A.; Spiess, S.; Gnamm, C.; Broedner, K.; Rominger, F.; Determined by HPLC with a Chiralcel AD-H column.
Helmchen, G. Chem.;Eur. J. 2010, 16, 6601–6615. (b) Spiess, S.; Raskatov,
J. A.; Gnamm, C.; Broedner, K.; Helmchen, G. Chem.;Eur. J. 2009, 15, catalytic activity of the iridium complex in the ring-opening
11087–11090. (c) Spiess, S.; Welter, C.; Franck, G.; Taquet, J.-P.; Helmchen,
G. Angew. Chem., Int. Ed. 2008, 47, 7652–7655. (d) Helmchen, G.; Dahnz, A.; reactions of N-Boc-azabenzonorbornadiene with N-methylani-
Duebon, P.; Schelwies, M.; Weihofen, R. Chem. Commun. 2007, 675–691. line. In the presence of 1 mol % of [Ir(COD)Cl]2 and 2 mol % of
(16) (a) Cho, Y. H.; Fayol, A.; Lautens, M. Tetrahedron: Asymmetry DPPF, the desired ring-opening product was obtained in a 71%
2006, 17, 416–427. (b) Lautens, M.; Fagnou, K.; Zunic, V. Org. Lett. 2002, 4,
3465–3468. (c) McManus, A. H.; Fleming, M. J.; Lautens, M. Angew. Chem., yield (Table 1, entry 1). The yield was increased to 86% when 1.5
Int. Ed. 2007, 46, 433–436. mol % of [Ir(COD)Cl]2 and 3 mol % of DPPF were employed
(17) (a) Lucet, D.; Le Gall, T.; Mioskowski, C. Angew. Chem., Int. Ed. 1998,
37, 2580–2627. (b) Hoppe, D.; Hense, T. Angew. Chem., Int. Ed. Engl. 1997, 36,
(Table 1, entry 2). However, further increase of the catalyst
2282–2316. (c) Beak, P.; Basu, A.; Gallagher, D. J.; Park, Y. S.; Thayumanavan, loading did not improve the yield (Table 1, entry 3). Several
S. Acc. Chem. Res. 1996, 29, 552–560. (d) Trost, B. M.; Van Vranken, D. L. chiral ligands such as (R)-(S)-PPF-PtBu2, (S)-(R)-NMe2-PPh2-
Chem. Rev. 1996, 96, 395–422. (e) Trost, B. M.; Van Vranken, D. L.; Bingel, C. J.
Am. Chem. Soc. 1992, 114, 9327–9343. (f) Trost, B. M.; Bunt, R. C.; Lemoine, Mandyphos, (S)-BINAP, (S)-p-Tol-BINAP, and L1 were then
R. C.; Calkins, T. L. J. Am. Chem. Soc. 2000, 122, 5968–5976. examined. From Table 1, we can see that (S)-BINAP gave
(18) (a) Szmuszkovicz, J.; VonVoigtlander, P. F.; Kane, M. P. J. Med. Chem. the best yield and enantioselectivity when the molar ratio of
1981, 24, 1230–1236. (b) Cowan, A.; Gmerek, D. E. Trends Pharmacol. Sci. 1986,
7, 69–72. (c) Millan, M. J. Trends Pharmacol. Sci. 1990, 11, 70–76. (S)-BINAP to iridium was 2:1 (Table 1, entry 6). While the
(19) (a) Xie, L.; Yang, D. Q.; Zhao, S. Q.; Wang, H.; Liang, L. H.; Luo, molar ratio of (S)-BINAP to iridium changed to 1:1 or 3:1, the
R. S. Chin. Chem. Lett. 2007, 18, 127–129. (b) Liu, E. C.; Yang, D. Q.; Han,
Y. F.; Dong, J. X. Chin. Chem. Lett. 2006, 17, 717–719.
ring-opening reaction gave a lower yield and enantioselectivity
(20) (a) Yang, D. Q.; Long, Y. H.; Wang, H.; Zhang, Z. M. Org. Lett. (Table 1, entries 9 and 10). Other ligands such as (R)-(S)-PPF-
2008, 10, 4723–4726. (b) Long, Y.-H.; Zhao, S.-Q.; Zeng, H.-P.; Yang, D.-Q. PtBu2, (S)-(R)-NMe2-PPh2-Mandyphos, (S)-p-Tol-BINAP,
Catal. Lett. 2010, 138, 124–133. (c) Long, Y.-H.; Yang, D.-Q.; Zeng, H.-P.;
Xie, L.; Wu, L.-H; Mo, H.-H.; Zuo, X.-J. Chin. J. Chem. 2010, 28, 235–242. and L1 gave either unsatisfactory results (Table 1, entries 4
(21) (a) Fache, F.; Schulz, E.; Tommasino, M. L.; Lemaire, M. Chem. and 7) or no reaction (Table 1, entries 5 and 8).
Rev. 2000, 100, 2159–2232. (b) Jacobsen, E. N.; Zhang, W.; Muci, A. R.; In order to obtain better yields and higher enantioselec-
Ecker, J. R.; Deng, L. J. Am. Chem. Soc. 1991, 113, 7063–7064. (c) Zhang,
W.; Loebach, J. L.; Wilson, S. R.; Jacobsen, E. N. J. Am. Chem. Soc. 1990, tivities for the asymmetric ring-opening reaction of aza-
112, 2801–2803. benzonorbornadiene with amine nucleopiles, a number of
(22) (a) Alexander van Vliet, L.; Tepper, P. G.; Dijkstra, D.; Damsma, G.;
Wikstrom, H.; Pugsley, T. A.; Akunne, H. C.; Heffner, T. G.; Glase, S. A.;
parameters including solvents, temperature, and additives
Wise, L. D. J. Med. Chem. 1996, 39, 4233–4237. (b) Degnan, A. P.; Meyers, have therefore been investigated. It was found that solvents
A. I. J. Org. Chem. 2000, 65, 3503–3512. (c) Marquet, A. Pure Appl. Chem. played a significant role in improving both reactivity
1993, 65, 1249–1252. (d) Hettinger, T. P.; Craig, L. C. Biochemistry 1970, 9,
1224–1232. (e) Umezawa, H.; Maeda, K.; Takeuchi, T.; Okami, Y. J. and enantioselectivity. The optimal solvent turned out to
Antibiot. Ser. A 1996, 19, 200–209. be tetrahydrofuran (THF). Iridium-catalyzed asymmetric
7292 J. Org. Chem. Vol. 75, No. 21, 2010
Long et al.
JOC Article
TABLE 2. Condition Screening for Iridium-Catalyzed Asymmetric TABLE 3. Iridium-Catalyzed Asymmetric Ring-Opening of 1 with
Ring-Opening Reaction of N-Boc-Azabenzonorbornadiene 1 with Secondary Amine Nucleophilesa
N-Methylanilinea
TABLE 4. Iridium-Catalyzed Asymmetric Ring Opening of 3 with TABLE 5. Iridium-Catalyzed Asymmetric Ring-Opening of 5 with
Secondary Amine Nucleophilesa Secondary Amine Nucleophilesa
a
The reaction was carried out with 5 (0.20 mmol) and 3.0 equiv of
amine (0.60 mmol) in THF (2.0 mL) at 80 °C (oil bath temperature) in
the presence of [Ir(COD)Cl]2 (1.5 mol %) and (S)-BINAP (3 mol %).
b
Isolated yield after silica gel column chromatography. cDetermined by
a
The reaction was carried out with 3 (0.20 mmol) and 3.0 equiv HPLC with a chiral stationary column (Chiralcel AD-H column for 6c;
of amine (0.60 mmol) in THF (2 mL) at 80 °C (oil bath temperature) in Chiralcel OD-H column for 6a and 6b).
the presence of [Ir(COD)Cl]2 (1.5 mol %) and (S)-BINAP (3 mol %).
b
Isolated yield after silica gel column chromatography. cDetermined by
HPLC with a chiral stationary column (Chiralcel AD-H column for 4a;
Chiralcel OD-H column for 4b, 4c and 4d). dThe reaction solvent is THP TABLE 6. Iridium-Catalyzed Asymmetric Ring-Opening of Azabicyc-
at 100 °C (oil bath temperature). lic Alkenes with Primary Aromatic Amine Nucleophilesa
Conclusions
We have developed an asymmetric ring-opening reaction of
N-subsitituted azabicyclic alkenes by a number of primary and
secondary amine nucleophiles in the presence of [Ir(COD)Cl]2/
(S)-BINAP catalyst. It provides an efficient and practical access
to the optically active 1,2-diamine derivatives in moderate to
good yields and enantioselectivities under mild conditions. Our
results further reveal that the nature of the chiral ligand has a
significant impact on this ring-opening reaction. The new
method is significant in terms of the low cost for the ligands
FIGURE 1. ORTEP plot for 2g. and facile manipulation compared to literature precedents. An
investigation on the biological and pharmaceutical activities of
the products is in progress. Studies on further expansion of the
SCHEME 1. Working Hypothesis for the Asymmetric Ring
Opening of N-Boc-Azabenzonorbornadiene 1 with a Secondary scope and synthetic utility of this Ir-catalyzed reaction are also
Amine Nucleophile being pursued in our laboratory.
Experimental Section
General. THF, THP, dioxane, and toluene were distilled from
sodium benzophenone ketyl immediately prior to use. CH3CN
and CH2Cl2 were distilled from calcium hydride. Azabenzonor-
bornadienes 1,20a 3,7 5,16b and [Ir(COD)Cl]220a were prepared
according to the reported procedures. All flasks were flame-
dried under a stream of nitrogen and cooled to room tempera-
ture before use. Solvents and solutions were transferred with
syringes and cannulae using standard inert atmosphere tech-
niques. All 1H and 13C NMR spectra were recorded at 400 and
100 MHz, respectively, using CDCl3 as a solvent. The chemical
shifts of all 1H and 13C NMR spectra are referenced to the
residual signal of CDCl3 (δ 7.27 ppm for the 1H NMR spectra
and δ 77.23 ppm for the 13C NMR spectra). Spectral features are
tabulated in the following order: chemical shift (δ, ppm); multi-
plicity (s-singlet, d-doublet, t-triplet, q-quadruplet, m-complex
multiplet, br-broad); coupling constants (J, Hz); number of pro-
tons. IR spectra were obtained using a KBr pellet or using a
neat film on a NaCl plate. MS spectra were recorded using ESI.
The melting points are uncorrected.
General Procedure (I) for the Asymmetric Ring-Opening Reac-
tions of N-Boc-Azabenzonorbornadiene 1 with Secondary Amine
Nucleophiles. A 5 mL round-bottom flask fitted with a reflux
condenser was flame-dried under a stream of nitrogen and cooled
The absolute configuration of ring-opened product 2g was to room temperature. [Ir(COD)Cl]2 (2.1 mg, 1.5 mol %) and
demonstrated by X-ray crystallography. The single crystal (S)-BINAP (3.9 mg, 3 mol %) were added, followed by the addi-
was obtained by solvent evaporation from a solution con- tion of anhydrous THF (2.0 mL). After the mixture was stirred
sisting of dichloromethane, petroleum ether, and ethyl ace- for 10 min at room temperature, N-Boc-azabenzonorbornadiene
1 (50 mg, 0.21 mmol) was added and the temperature of the oil
tate. Its configuration was assigned as (1R,2R) and confirmed
bath was increased to 80 °C. On the first sign of reflux, nucleo-
as 1,2-trans-configuration, as shown in Figure 1. It is obvious phile (3-5 equiv to 1) was added. The reaction was stirred at
that the reaction favors the formation of trans-1,2-diamino 80 °C until completion as monitored by thin layer chromatogra-
products. phy. After the reaction mixture was cooled to room temperature,
On the basis of our studies, a working hypothesis is shown in the solvent was removed in vacuo and the residue was purified by
Scheme 1. First, the chiral dimeric iridium complex A is formed. column chromatography on silica gel (200-300 mesh) to give the
The nitrogen atom and the double bond of N-Boc-azabenzo- desired product.
norbornadiene 1 are then reversibly coordinated to the iridium (1R,2R)-[2-(Methylphenylamino)-1,2-dihydronaphthalen-1-yl]-
center of the catalyst to give the intermediate B. In this step, carbamic acid tert-butyl ester (2a). Following the general proce-
the intermediate B containing a larger Boc group is less dure (I), 2a was obtained as a white solid (40.2 mg, 56%): Rf =
0.24 on silica gel (ethyl acetate/petroleum ether = 1:20, v/v); mp
stable than the counterpart containing a relatively smaller
160-161 °C; ee was determined to be 84% using HPLC analysis
Ts group. Insertion of the iridium into the C-N bond of on a Chiralcel AD column (hexane/2-propanol = 90/10, 0.5 mL/
B forms C. Nucleophilic attack of C by an amine nucleo- min, λ = 254 nm); retention times were 11.4 min (minor) and 12.5
phile occurs in an SN20 displacement of the iridium catalyst min (major); [R]20D = -31.8 (c = 1.00, CHCl3); IR (KBr, cm-1)
with an inversion of configuration. Electron-rich amine 3380(s), 3063(w), 2976(w), 2819(w), 1688(s), 1575 (s), 1525(m),
nucleophiles are beneficial for the nucleophilic attack. The 1406(m), 1178(s), 1050(w), 745(m); 1H NMR (400 MHz, CDCl3)
δ 7.34 (d, J = 6.4 Hz, 1H), 7.21 (t, J = 7.6 Hz, 3H), 7.10 (d, J = (d, J=9.2 Hz, 1H), 2.95 (s, 3H), 1.27 (s, 9H); 13C NMR (100 MHz,
5.2 Hz, 1H), 6.85 (d, J = 7.6 Hz, 2H), 6.72 (t, J = 6.0 Hz, 1H), CDCl3) δ 155.2, 154.4, 137.3, 134.3, 132.3, 131.0, 128.5, 128.4,
6.61 (d, J = 5.2 Hz, 1H), 5.93 (d, J = 9.6 Hz, 1H), 5.20 (t, J = 127.3, 127.1, 126.3, 126.0, 111.2, 79.9, 60.5, 52.3, 33.8, 28.2;
10.0 Hz, 1H), 4.79 (d, J = 10.0 Hz, 1H), 4.51 (d, J = 9.2 Hz, 1H), MS (ESI) calcd m/z for C22H25N3O4 (Mþ) 395.18, found 418.24
2.83 (s, 3H), 1.34 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 155.4, (M þ Na)þ. Anal. Calcd for C22H25N3O4: C, 66.82; H, 6.37; N,
150.1, 135.8, 130.0, 129.1, 128.0, 127.9, 126.6, 125.8, 121.0, 117.1, 10.63. Found: C, 66.69; H, 6.20; N, 10.33.
114.8, 113.6, 79.5, 60.7, 52.4, 33.0, 28.3; MS (ESI) calcd m/z for (1R,2R)-{2-[(4-Bromophenyl)methylamino]-1,2-dihydronaphtha-
C22H26N2O2 (Mþ) 350.20, found 351.03 (M þ H)þ. Anal. Calcd len-1-yl}carbamic acid tert-butyl ester (2g). Following the general
for C22H26N2O2: C, 75.40; H, 7.48; N, 7.99. Found: C, 75.69; procedure (I), 2g was obtained as a white solid (25.6 mg, 29%):
H, 7.20; N, 8.23. Rf = 0.16 on silica gel (ethyl acetate/petroleum ether = 1:25, v/v);
(1R,2R)- [2-(Ethylphenylamino)-1,2-dihydronaphthalen-1-yl]- mp 179-181 °C; ee was determined to be 65% using HPLC
carbamic acid tert-butyl ester (2b). Following the general proce- analysis on a Chiralcel AD column (hexane/2-propanol = 90/10,
dure (I), 2b was obtained as a white solid (34.4 mg, 45%): Rf = 0.5 mL/min, λ = 254 nm); retention times were 10.6 min (minor)
0.19 on silica gel (ethyl acetate/petroleum ether = 1:25, v/v); mp and 11.6 min (major)l [R]20D = -78.3 (c = 1.00, CHCl3); IR (KBr,
128-129 °C; ee was determined to be 76% using HPLC analysis cm-1) 3374(m), 3043(m), 2963(m), 2920(w), 1682(s), 1520 (s),
on a Chiralcel AD-H column (hexane/2-propanol = 95/5, 0.5 1495(s), 1366(m), 1108(m), 783(m); 1H NMR (400 MHz, CDCl3)
mL/min, λ = 254 nm); retention times were 14.4 min (minor) δ 7.32-7.21 (m, 4H), 7.11 (d, J = 6.0 Hz 1H), 6.73 (d, J = 8.8 Hz,
and 21.3 min (major); [R]20D = -56.5 (c = 1.00, CHCl3); IR 2H), 6.61 (dd, J = 12.0 Hz, 7.6 Hz, 1H), 5.87 (dd, J=12.4 Hz,
(KBr, cm-1) 3355(w), 3248(w), 2975 (w), 2927(w), 1696(s), 6.8 Hz, 1H), 5.16 (t, J = 9.6 Hz, 1H), 4.67 (d, J = 9.6 Hz, 1H), 4.52
1596(s), 1505(s), 1365(m), 1249(w), 1116(s), 987(m), 781(w), (d, J = 8.8 Hz, 1H), 2.78 (s, 3H), 1.34 (s, 9H); 13C NMR (100 MHz,
745(m), 642(w); 1H NMR (400 MHz, CDCl3) δ 7.35 (d, J = CDCl3) δ 155.2, 149.0, 135.4, 132.6, 131.7, 130.2, 129.0, 128.1,
6.8 Hz, 1H), 7.26 (t, J = 8. 0 Hz, 3H), 7.13 (d, J = 6.4 Hz, 1H), 128.0, 126.8, 125.9, 115.1, 108.8, 79.6, 60.8, 52.2, 33.2, 28.2; MS
6.91 (d, J = 8.4 Hz, 2H), 6.75 (t, J = 7.2 Hz, 1H), 6.65 (dd, J = (ESI) calcd m/z for C22H25BrN2O2 (Mþ) 428.11, found 429.03
11.6 Hz, 8.0 Hz, 1H), 6.00 (dd, J = 12.0 Hz, 6.8 Hz, 1H), 5.20 (t, (M þ H)þ. Anal. Calcd for C22H25BrN2O2: C, 61.54; H, 5.87; N,
J = 9.2 Hz, 1H), 4.74 (d, J = 8.4 Hz, 1H), 4.63 (d, J = 8.8 Hz, 6.52. Found: C, 61.23; H, 5.62; N, 6.86.
1H), 3.32 (q, 2H), 1.43 (s, 9H), 1.11 (t, J = 6.8 Hz, 3H); 13C (1R,2R)-[2-(3,4-Dihydro-2H-quinolin-1-yl)-1,2-dihydronaphtha-
NMR (100 MHz, CDCl3) δ 155.2, 148.3, 135.5, 132.6, 130.2, len-1-yl]carbamic acid tert-butyl ester (2h). Following the general
129.2, 128.8, 128.1, 128.0, 126.8, 125.9, 121.7, 116.9, 114.7, 79.6, procedure (I), 2h was obtained as a white solid (51.4 mg, 65%):
61.0, 33.2, 28.3, 13.9; MS (ESI) calcd m/z for C23H28N2O2 (Mþ) Rf = 0.25 on silica gel (ethyl acetate/petroleum ether = 1:25, v/v);
364.22, found 364.97. Anal. Calcd for C23H28N2O2: C, 75.79; H, mp 120-121 °C; ee was determined to be 75% using HPLC
7.74; N, 7.69. Found: C, 75.69; H, 7.71; N, 7.92. analysis on a Chiralcel OD-H column (hexane/2-propanol = 90/
(1R,2R)-[2-(Allylphenylamino)-1,2-dihydronaphthalen-1-yl]- 10, 0.5 mL/min, λ = 254 nm); retention times were 9.5 min (major)
carbamic acid tert-butyl ester (2c). Following the general pro- and 12.8 min (minor); [R]20D = -56.4 (c = 1.00, CHCl3); IR (KBr,
cedure (I), 2c was obtained as a white solid (22.2 mg, 28%): cm-1) 3372(s), 2927(w), 1688(w), 2898(m), 1600(w), 1499(m),
Rf = 0.19 on silica gel (ethyl acetate/petroleum ether = 1:25, v/v); 1365(w), 1301(w), 1250(w), 1169(m), 1048(w), 783(w), 742(w); 1H
mp 111-113 °C; ee was determined to be 69% using HPLC NMR (400 MHz, CDCl3) δ 7.36 (d, J = 6.4 Hz, 1H), 7.24-7.21 (m,
analysis on a Chiralcel AD column (hexane/2-propanol = 95/5, 1H), 7.10 (d, J = 6.8 Hz, 1H), 7.02 (t, J = 7.8 Hz, 1H), 6.96 (d, J =
0.5 mL/min, λ = 254 nm); retention times were 14.7 min (minor) 7.2 Hz, 1H), 6.78 (d, J = 8.0 Hz, 1H), 6.63-6.56 (m, 2H), 5.91 (d,
and 18.9 min (major); [R]20D = -56.1 (c = 1.00, CHCl3); IR (KBr, J = 9.6 Hz, 1H), 5.28 (t, J = 9.8 Hz, 1H), 4.80 (d, J = 9.6 Hz, 1H),
cm-1) 3356(w), 2975(m), 2927(m), 1709(s), 1597(m), 1503(m), 4.62 (s, 1H), 3.22 (s, 2H), 2.72 (t, J = 6.4 Hz, 2H), 1.94-1.80 (m,
1456(w), 1367(s), 1332(s), 1252(s), 1168(s), 1074(m), 858(w), 2H), 1.35 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 155.5, 145.4,
782(w), 747(m), 694(w), 542(w); 1H NMR (400 MHz, CDCl3) 136.0, 132.8, 130.1, 129.5, 128.0, 127.8, 126.9, 126.6, 126.3, 125.9,
δ 7.31 (d, J = 7.2 Hz, 1H), 7.27-7.18 (m, 3H), 7.11 (d, J = 6.4 Hz, 123.6, 116.1, 111.2, 79.5, 58.3, 51.7, 43.5, 28.3, 28.2, 22.3; MS (ESI)
1H), 6.88 (d, J = 7.6 Hz, 2H), 6.72 (t, J = 7.0 Hz, 1H), 6.61 (d, J = calcd m/z for C24H28N2O2 (Mþ) 376.22, found 399.33 (M þ Na)þ;
9.6 Hz, 1H), 5.98 (d, J = 9.2 Hz, 1H), 5.78-5.73 (m, 1H), 5.16 (d, Anal. Calcd for C24H28N2O2: C, 76.56; H, 7.50; N, 7.44. Found: C,
J = 8.4 Hz, 1H), 5.12 (d, J = 6.0 Hz, 1H), 5.07 (d, J = 10.0 Hz, 76.31; H, 7.18; N, 7.63.
1H), 4.81 (d, J = 6.4 Hz, 1H), 4.58 (d, J = 6.8 Hz, 1H), 3.84 (s, (1R,2R)-[2-(3,4-Dihydro-1H-isoquinolin-2-yl)-1,2-dihydro-
2H), 1.37 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 155.2, 148.4, naphthalen-1-yl]carbamic acid tert-butyl ester (2i). Following the
135.7, 135.4, 132.5, 130.0, 129.0, 128.7, 128.1, 128.0, 126.7, 124.8, general procedure (I), 2i was obtained as colorless oil (22.9 mg,
117.1, 115.7, 114.2, 79.5, 59.7, 52.3, 29.7, 28.3; MS (ESI) calcd m/z 29%): Rf =0.37 on silica gel (ethyl acetate/petroleum ether=1:6,
for C24H28N2O2 (Mþ) 376.22, found 399.24 (M þ Na)þ. Anal. v/v); ee was determined to be 64% using HPLC analysis on a
Calcd for C24H28N2O2: C, 76.56; H, 7.50; N, 7.44. Found: C, 76.69; Chiralcel OD-H column (hexane/2-propanol = 90/10, 0.5 mL/
H, 7.80; N, 7.23. min, λ = 254 nm); retention times were 10.2 min (major) and
(1R,2R)-{2-[Methyl-(4-nitrophenyl)amino]-1,2-dihydronaphtha- 12.5 min (minor); [R]20D =-84.5 (c = 1.00, CHCl3); IR (KBr,
len-1-yl}carbamic acid tert-butyl ester (2f). Following the general cm-1) 3346(m), 3065(m), 2976 (m), 2926(m), 2803(w), 1707(s),
procedure (I), 2f was obtained as a yellow solid (20.7 mg, 25%): 1496(s), 1453(m), 1365(m), 1248(m), 1167(s), 1093(w), 1044(w),
Rf = 0.39 on silica gel (ethyl acetate/petroleum ether = 1:4, v/v); 1022(w), 934(w), 780(w), 741(m); 1H NMR (400 MHz, CDCl3) δ
mp 151-152 °C; ee was determined to be 61% using HPLC 7.34 (d, J = 7.2 Hz, 1H), 7.28-7.21 (m, 1H), 7.12 (d, J = 6.8 Hz,
analysis on a Chiralcel AD-H column (hexane/2-propanol = 90/ 1H), 7.05 (d, J = 7.2 Hz, 3H), 6.94 (d, J = 6.8 Hz, 1H), 6.68
10, 0.5 mL/min, λ = 254 nm); retention times were 30.4 min (d, J = 9.6 Hz,1H), 6.30 (dd, J = 12.8 Hz, 5.2 Hz, 1H), 5.10 (br s,
(minor) and 36.5 min (major); [R]20D = -124.3 (c = 1.00, CHCl3); 1H), 4.65 (dd, J = 10.0 Hz, 2.0 Hz, 1H), 3.90 (d, J=14.8 Hz, 1H),
IR (KBr, cm-1) 3353(m), 3065(w), 2976(w), 2920(w), 1686(s), 3.73 (d, J = 15.2 Hz, 1H), 3.60 (t, J =4.8 Hz, 1H), 2.87-2.80
1595(s), 1510(s), 1392(m), 1366(w), 1316(s), 1166(m), 1104(m), (m, 4H), 1.43 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 155.2,
1008(w), 938(w), 825(w), 784(m), 751(m), 616(w), 562(m); 1H 135.3, 135.2, 134.5, 132.4, 129.7, 128.7, 128.3, 128.1, 127.7, 126.8,
NMR (400 MHz, CDCl3) δ 8.01 (d, J = 7.6 Hz, 2H), 7.34 (d, 126.6, 125.8, 125.8, 125.4, 79.5, 63.5, 51.4, 48.5, 46.6, 29.9, 28.4;
J = 7.2 Hz, 1H), 7.29-7.22 (m, 1H), 7.13 (d, J = 6.8 Hz, 1H), MS (ESI) calcd m/z for C24H28N2O2 (Mþ) 376.22, found 399.03
6.81 (d, J = 7.6 Hz, 2H), 6.67 (d, J = 9.6 Hz, 1H), 5.85 (d, J = 10.0 (M þ Na)þ. Anal. Calcd for C24H28N2O2: C, 76.56; H, 7.50; N,
Hz, 1H), 5.17 (t, J = 9.6 Hz, 1H), 4.97 (d, J = 9.2 Hz, 1H), 4.62 7.44. Found: C, 76.69; H, 7.20; N, 7.63.